Average Co-Inventor Count = 6.04
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Boehringer Ingelheim Pharmaceuticals, Inc. (6 from 276 patents)
2. Pharmacyclics, Inc. (3 from 193 patents)
3. Bikam Pharmaceuticals Inc. (3 from 7 patents)
4. Columbia University (2 from 2,489 patents)
5. Nimbus Iris, Inc. (2 from 10 patents)
16 patents:
1. 9757370 - Opsin-binding ligands, compositions and methods of use
2. 9708326 - Inhibitors of bruton's tyrosine kinase
3. 9580416 - Inhibitors of Bruton's tyrosine kinase
4. 9499464 - Opsin-binding ligands, compositions and methods of use
5. 9469642 - Purinone compounds as kinase inhibitors
6. 9402826 - Neuronal pain pathway modulators
7. 9353063 - Opsin-binding ligands, compositions and methods of use
8. 9340554 - IRAK inhibitors and uses thereof
9. 8846742 - Neuronal pain pathway modulators
10. 8703941 - IRAK inhibitors and uses thereof
11. 7279472 - Compounds useful as reversible inhibitors of cysteine proteases
12. 7265132 - Compounds useful as reversible inhibitors of cysteine proteases
13. 6420364 - Compound useful as reversible inhibitors of cysteine proteases
14. 6414153 - 1-phenylpydrrolidin-2-ones and -thiones and 1-(4-pyridyl)pydrrolidin-2-ones and -thiones which are useful in the treatment of inflammatory disease
15. 6395897 - Nitrile compounds useful as reversible inhibitors of #9 cathepsin 5